Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Raffeld

Showing results (211-220 of 276) with videos related to

Pageof 28
Sort By:
Blood|December 14, 2016
Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrheaChi A Ma, Liqiang Xi, Brian Cauff, et al.
The Journal of Experimental Medicine|April 26, 2006
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcomaAarif Y Khakoo, Shibani Pati, Stasia A Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2020
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell LeukemiaDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Urologic Oncology|November 12, 2025
Multigenerational VHL family characterized by pathogenic germline ELOC variant: Response to belzutifanCathy D Vocke, Christopher J Ricketts, Lidenys O'Brien, et al.
Cancer Research|January 22, 2009
Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylomeJ Keith Killian, Sven Bilke, Sean Davis, et al.
JCO Precision Oncology|July 16, 2025
Complete Response in Hairy Cell Leukemia to Anti-CD22 CAR T-Cell TherapyRobert J Kreitman, Brett Schroeder, Evgeny Arons, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 19, 2019
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With GlioblastomaStephanie L Goff, Richard A Morgan, James C Yang, et al.
The American Journal of Surgical Pathology|July 15, 2011
Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentationAdriana Garcia-Herrera, Joo Y Song, Shih-Sung Chuang, et al.
The New England Journal of Medicine|July 31, 2025
Resolution of Squamous-Cell Carcinoma by Restoring T-Cell Receptor SignalingPeiying Ye, Jenna R E Bergerson, Isaac Brownell, et al.
Blood Advances|October 3, 2024
Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasmsNeval Ozkaya, Sarah Melloul Benizri, Girish Venkataraman, et al.
Pageof 28

Showing results (211-220 of 276) with videos related to

Sort By:
Pageof 28
Blood|December 14, 2016
Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrheaChi A Ma, Liqiang Xi, Brian Cauff, et al.
The Journal of Experimental Medicine|April 26, 2006
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcomaAarif Y Khakoo, Shibani Pati, Stasia A Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2020
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell LeukemiaDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Urologic Oncology|November 12, 2025
Multigenerational VHL family characterized by pathogenic germline ELOC variant: Response to belzutifanCathy D Vocke, Christopher J Ricketts, Lidenys O'Brien, et al.
Cancer Research|January 22, 2009
Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylomeJ Keith Killian, Sven Bilke, Sean Davis, et al.
JCO Precision Oncology|July 16, 2025
Complete Response in Hairy Cell Leukemia to Anti-CD22 CAR T-Cell TherapyRobert J Kreitman, Brett Schroeder, Evgeny Arons, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 19, 2019
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With GlioblastomaStephanie L Goff, Richard A Morgan, James C Yang, et al.
The American Journal of Surgical Pathology|July 15, 2011
Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentationAdriana Garcia-Herrera, Joo Y Song, Shih-Sung Chuang, et al.
The New England Journal of Medicine|July 31, 2025
Resolution of Squamous-Cell Carcinoma by Restoring T-Cell Receptor SignalingPeiying Ye, Jenna R E Bergerson, Isaac Brownell, et al.
Blood Advances|October 3, 2024
Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasmsNeval Ozkaya, Sarah Melloul Benizri, Girish Venkataraman, et al.
Pageof 28